2015 DRUG REPORT Pennsylvania State Coroners Association

Pennsylvania State Coroners Association
Report on Overdose Death

Statistics
2015
To the living we owe respect, but to the dead we owe only the truth. Voltaire
And I looked, and behold a pale horse: and his name that sat upon him was Death
Revelations Chapter 6 Verse 8
This report in the following pages provides statistics on deaths where drugs caused or contributed to the death of an
individual. In reviewing the numbers on these pages we must be mindful that each number represents a history of an
individual with hopes and dreams and families and friends. It is hoped that these numbers can assist in developing
policies that will help abate this terrible scourge of drug related deaths.
This years report would like to highlight a group of families from Butler
County as they are coping with the drug addiction in their lives. They are
engaged in many activities to highlight the problem and to help find solutions.
As summed up by one mother:
But we have to stop the stigma & stop the silence!! Im a firm believer in that.
Hope for Broken Hearts is a family support group for people affected first hand, with loved ones
caught up in addiction. It was started to give families a safe, confidential place to release their
emotions and frustrations when dealing with addiction.
This group focuses on hope, support, education and saving lives. All people need the hope of turning
around devastating situations. Members can speak openly about their experiences and their fears
that other people cannot begin to understand. We support each other and gain strength in support
and knowledge. Educating each other is important. We need to understand what opiates do to loved
ones in order to deal with the devastation it causes. Along with the education is being prepared for
an overdose. Overdoses happen anywhere at any time. Most of the members have been trained
and carry Naloxone (Narcan) at all times. All lives are worth saving.
The drug epidemic does not just affect the families. This affects the community either directly or
indirectly. We are losing people to addiction. This affects all families, every neighborhood, and every
social status. No one is immune.
We need education on all levels. We need to have reality drug education in schools. The programs
need to be more in depth than being told drugs are bad & just say no. They need to know the reality.
They need to know what heroin does to the brain after just trying it once or twice. People need to
know, too. Some would rather waste time debating if it is a choice or a disease. Yes, it was a choice
the first time or two. After that it changes the way the brain functions. People are dying every day.
We need to do more than talk about it. When the way we have done things for years doesnt work, it
is time to do something different.
Hope for Broken Hearts has been doing a variety of things to help get the heroin epidemic out in the
public eye.
Some of the things we have done include:
o Sent letters to doctors & dentists in the area to encourage them to not write prescriptions for
opiates when there is an alternative medicine.
o Recognized by Butler County Commissioners with a proclamation declaring May as Drug
Awareness Month.
o Traveled to another county for Naloxone (Narcan) training for our group.
o Set up first Naloxone Training in Butler County, with 90 people in attendance receiving lifesaving naloxone take-home kits. (We had a waiting list for this class.)
o Spoke at CJAB (Butlers Criminal Justice Advisory Board).
o Sought out needed grant information for Naloxone. Through CJAB, police in Butler City, Butler
Township & various boroughs were able to be trained & carry Naloxone.
o Attended various drug summits.
o Held Drug Awareness Seminar at Butler County Community College with educated speakers
active in dealing with addiction.
o Held first annual Candlelight Overdose Walk in Butler (Fall 2015).
3
o Participated in week long informative booth at Butler Farm Show, talking, listening and sharing
information. Heard both heartbreaking reality stories & also positive recovery stories.
o Took part in the Butler Fall Festival & RiverFest in East Brady, handing out information.
o Spoke at various county level meetings.
o Took part in a webinar phone call with the White House regarding the drug epidemic.
o Attended a Relapse seminar in another county.
o Recognized from The Gaiser Addiction Center at a special Valentines Breakfast, as they also
handed out free naloxone kits to participants.
o Held our 1st free community movie night, showing documentary of a town that completely
turned their community around from their drug use. (An Appalachian Dawn) Very positive
responses. Others want to show the movie at their churches.
o Held our 3rd annual drug awareness walk (Walk of Hope) in downtown Butler in May of 2016.
This years Walk of Hope had a record number in attendance despite the rain. Every year it keeps
growing. There were a couple of speakers. There were pastors from different churches to offer up
prayer for the families, the ones fighting addiction, the ones in recovery, and for our community.
We are encouraging others to find a family support group in their community. There are many hurting
families that need to know they are not alone. If you cannot find a group that fits your needs, start
one. Together, a few people can do great things. Our core group is small. We have done all these
things within 2 years. Everyone can make a difference. We cannot just sit back and watch this
devastation destroy our families and loved ones. We need to speak up. We need to let them know
there is hope. Recovery is possible. Things can get better.
We believe there is HOPE of recovery. Our group is there to SUPPORT each other. We emphasis
the importance of EDUCATION, not only within our group, but with the public. We understand the
importance of SAVING LIVES. Every life is worth saving.
Charlene Eckert
Hope for Broken Hearts
(support for families of addiction)
Mt. Chestnut Presb. Church

727 W Old 422
Butler, PA 16001
TABLE OF CONTENTS
INTRODUCTION
TABLE OF CONTENTS
DATA COLLECTION
REPORT SUMMARY
GLOSSARY OF DRUGS
PENNSYLVANIA STATEWIDE STATISTICS OVERVIEW
COUNTY MAP OF PENNSYLVANIA
REGIONAL MAP OF PENNSYLVANIA
DRUG DEATHS PER 100,000 POPULATION
COMPARISON 2014 TO 2015
COMPARISON RURAL AND URAN COUNTIES
CHARTS
OVERDOSES
OPIOID MEDICATIONS
BENZODIAZEPINES
ANTIDEPRESSANTS
ANTIHISTAMINES
ANTIPSYCHOTICS
ANTICONVULSANTS
MUSCLE RELAXERS
BARBITUATES
HYPNOTICS
ILLEGAL DRUGS
DRUGS BY CLASSIFICATION
WEEKDAY
TIME
MONTH
GENDER
RACE
MARITAL STATUS
AGE
COUNTIES
ADAMS
ALLEGHENY
ARMSTRONG
BEAVER
BEDFORD
BERKS
BLAIR
BRADFORD
BUCKS
BUTLER
CAMBRIA
CAMERON
CARBON
CENTRE
CHESTER
CLARION
CLEARFIELD
2
5
7
8
11
14
15
16
17
18
19
19
20
20
20
21
21
21
21
22
22
23
23
23
23
23
23
24
25
27
29
31
33
34
36
38
40
42
44
46
47
49
51
53
54
5
CLINTON
COLUMBIA
CRAWFORD
CUMBERLAND
DAUPHIN
DELAWARE
ELK
ERIE
FAYETTE
FOREST
FRANKLIN
FULTON
GREENE
HUNTINGTON
INDIANA
JEFFERSON
JUNIATA
LACKAWANNA
LANCASTER
LAWRENCE
LEBANON
LEHIGH
LUZERNE
LYCOMING
MCKEAN
MERCER
MIFFLIN
MONROE
MONTGOMERY
MONTOUR
NORTHAMPTON
NORTHUMBERLAND
PERRY
PHILADELPHIA
PIKE
POTTER
SCHUYLKILL
SNYDER
SOMERSET
SULLIVAN
SUSQUEHANNA
TIOGA
UNION
VENANGO
WARREN
WASHINGTON
WAYNE
WESTMORELAND
WYOMING
YORK
CONCLUSION
56
57
59
60
62
64
66
67
69
71
72
74
75
77
79
81
82
83
84
86
88
90
92
94
96
97
99
100
102
104
105
107
108
109
111
112
113
115
116
118
119
120
121
122
124
125
127
129
131
132
134
Data Collection
For the period of January December 2015, the Coroners and Medical Examiners of the Commonwealth reported 3,505
deaths resulting from drug poisoning. This number may not reflect all drug related deaths for the time period, since
there is lag time in getting toxicology reports and autopsy reports completed and not all drug related deaths may have
been reported to the Coroner or Medical Examiner. Therefore, the current totals may ultimately be increased. Of the
cases investigated by the Commonwealths Coroners and Medical Examiners, toxicology results determined that the
drugs listed below were present at the time of death. It is important to note that each death is a single case, while each
time a drug is detected represents an occurrence. The vast majority of the decedents had more than one drug
occurrence.
A drug is indicated as the cause of death only when, after examining all evidence and the autopsy and/or toxicology
results, the Coroner/Medical Examiner determines the drug is present or identifiable in the deceased and has played a
causal or contributing role in the death. It is not uncommon for a decedent to have multiple drugs listed as a cause of
death. This report is limited to deaths where the manner of death is accident, suicide, homicide or undetermined. The
reported deaths herein do not include natural deaths, where there may be a significant number of drugs in the persons
system, but the drugs are not determined to be the cause of death. But, if the drugs were determined to have a
underlying impact on a death, which is otherwise due to medical complications, it is included in this report even though
it has been determined to be a natural death.
Data and demographics may be missing or flawed from certain counties which will alter the outcome of various totals to
a certain degree.
Of the 67 counties data has been received from all 67 counties. The Coroners and Medical Examiners who took time out
of their busy schedules serving the people of their counties in determining the cause and manner of death of those who
have died as a result of violent acts, unintentional or intentional, are gratefully acknowledged. Without their assistance
this report would not have been possible.
Any perceived opinions in this Report are those of the compiler of the Report and do not necessarily
reflect the opinions of the Pennsylvania State Coroners Association, nor any individual Coroner or Medical
Examiner in the State of Pennsylvania.
Susan M. Shanaman, Attorney
PSCA Solicitor/Legislative Liaison
This report is the work product of the Pennsylvania State Coroners Association, is subject to attorney-client privilege
and may not be copied without express permission and may not be used without the attribution to the source.
7
Report Summary
The CDC has stated that our country is in the midst of an overdose epidemic.
The New York Times quoted Dr. Hamilton Wright of Ohio stating Of all the nations of the world, America
consumes the most opium in one form or another. The habit has this Nation in its grip to an astonishing extent.
The drug habit has spread throughout America until it threatens us with a very serious disaster. What is
astonishing about these comments is not that they were said, but when they were said. These remarks were made
in 1911 by the first appointed US Drug Czar (appointed by President Theodore Roosevelt).
Drug related deaths have continued to increase. In 2014 that number reached at least 2,489 individuals. The year
2014 showed an average increase of about 20% over the prior year for many counties. In 2015 the number of drug
related deaths increased to 3,505 or a 30% increase over the prior year. If, initial data for 2016 is any indication,
the number of deaths will continue to increase.
Ten (10) people die every day in Pennsylvania from drug related causes. Not known are the number of persons
who overdose but survive. In addition, this number may be somewhat conservative since many hospitals will
throw away admission blood after three days, leaving nothing to be forensically analyzed in case of death.
The age of the deceased ranges from under 2 months to 94 years of age. The majority of deaths are found in the age
group 30 39 years old, but with the vast majority occurring between the ages of 30 49 years old. Men represent
2/3rds of the deaths. Deaths are split along racial lines in accordance with the percentages represented in the
Commonwealth. The typical decedent is single, either never been married, divorced or widowed.
Most deaths are the result of multiple prescription drugs either alone or with the addition of heroin or cocaine, to a
lesser degree. In addition, there has been a significant increase in the number of heroin deaths which were
accompanied by the addition of fentanyl or acetyl fentanyl. Also, the use of cocaine to which levamisole has been
added continue to increase. Lastly, there is an increase in the presence of THC found in marijuana and synthetic
cannabinoids. The latter drug is also seen increasingly in statistics reported by the PSP on impaired driving.
Found in 14% of the toxicology reports of the drug related deaths are the opioids generally prescribed to treat
addiction or overdose events, methadone, buprenorphine (found either as suboxone or subutex), naloxone,
naltrexone. Methadone is prescribed in clinics under the regulation of the Substance Abuse and Mental Health
Services Administration (SAMSHA) and the Pennsylvania Drug and Alcohol Programs. To prescribe buprenorphine,
the prescriber only needs to secure a DEA authorization.
As stated by US Senator Tim Murphy at the beginning of hearings he is chairing into the issue of Examining The
Growing Problem Of Prescription Drug And Heroin Abuse: State And Local Perspectives, March 26, 2015:
Buprenorphine can more safely maintain a persons dependence by reducing
the need for illegal opioid use, such as heroin, and thereby the risk for overdose. But
make no mistake, buprenorphine is a highly potent opioid, which according to SAMSHA,
is 20 to 50 times more potent than morphine. So it is worth considering that our national
strategy to combat substance abuse is to maintain addiction by either prescribing or
administering a heroin-replacement opioid. And unlike clinics that administer methadone,
there are no requirements for buprenorphine clinics to offer or even discuss non-addictive
treatment alternatives, no requirement to develop treatment plans, no requirements to
protect the public against it being diverted for illicit use.
Statewide drug related deaths occur throughout the year with a slight increase in October. (In 2014 the slight
increase was in May.) Deaths generally increase on the weekends and 2/3rds of the deaths occur between the
hours of 4 PM and 8 AM.
There are several ways in which these drug related deaths may be characterized and each requires a solution
which considers the unique variables. There is the group of children either born with NAS or toddlers exposed to
drugs and those drugs used for treatment who in error access them with fatal results. There is the group of teens
and younger adults who are experimenting with drugs, perhaps as a matter of peer pressure. There is the vast
majority of adults who perhaps believe that the American Dream has passed them by, have become addicted and
see no clear path to recovery or have been unable to readily access the means of recovery. There are the elder
citizens who are generally not experimenting with illegal drugs but are overdosing on prescribed medications. And,
lastly, there are the veterans who have volunteered to serve our country and who come home with medical issues
and mental health issues for which they have been receiving inadequate treatment in the form of a cocktail of
drugs a sleeping pill, anti-anxiety medication, an anti-depressant, and an anti-psychotic and sometimes, even a
stimulant.1
While the Federal Mental Health Parity Law requires parity for addiction treatment, that parity remains elusive.
There are insurance companies who dont do admitting paperwork on a weekend, there are a scarcity of pain
management practices or clinics, there is an apparent lack of facilities with beds to provide long term treatment or
to accept mothers with their small children, so as to not needlessly further tear apart families during the healing
process.
There needs to be a stronger tying of an overdose incident with the treatment process. Merely handing someone a
card with locations of any treatment programs in the area doesnt appear to be adequate. If someone is ready to
commit to getting treatment, suggesting treatment may be available in a couple of days or weeks is not adequate.
And while there are appropriate, necessary privacy concerns and Constitutional issues involving the 14th
Amendment regarding involuntary commitments for treatment, providing Narcan without further follow-up is
probably just changing the date of death.
There needs to be a scalpel brought to the discussion of broad based policies to stem the tide of this drug
pandemic. Take for example, an elderly women who has been diagnosed with pain generating medical issues. She
has been given a prescription to relieve the pain while waiting 4 months to get another appointment with a
specialist. This prescription is only valid for two weeks. After two weeks she has to get a relative to take her to the
doctor to get another two week supply. She has no diagnosed tendencies to abuse or divert the drugs for another
use, she has been caught in a system to try to stop abuse.
Another example is a mother with a child who has been diagnosed with ADHD. She can get a thirty day supply of
the needed drugs, but to get a refill she must travel at least half an hour and on the precise day the prescription
runs out to get a refill. Again, there are no indications of drug abuse or diversion of the use of the drugs for another
purpose, she has been caught up in a one-size-fits-all system to stop drug abuse.
Can we not trust any of our physicians to exercise judgment in filling prescriptions? Shouldnt the ABC-MAP Act of
2014 provide the information necessary to catch those who would abuse their ability to prescribe?
Another obvious conclusion from reviewing the data relates to the number of drugs found in an individuals
toxicology. While the average number of drugs, both prescription and illegal is about 3 per person, there are too
many instances where an individual may be found with multiples of a classification of drugs. An example is the
toxicology of one individual who had five antidepressants in their toxicology. Why would anyone take such
multiples of one type of drug? Perhaps part of the answer may be found in the current use of drugs for off-label
purposes. For example, antidepressants are prescribed by various physicians for treatment of disorders other than
depression -- anxiety, sleep issues, pain, headaches, smoking cessation, premenstrual syndrome, premature
ejaculation2. In fact the CDC has indicated that the rate of use of antidepressants has increased nearly 400% since
1988.
1
2
The Militarys Prescription Drug Addiction, The American Conservative, Kelley Beaucar, October 3, 2013
5 Surprising Uses for Antidepressants, Wyatt Myers, www.everydayhealth.com
Another concern is when a patient is hospitalized after a nonfatal prescription opioid-related overdose, leaves the
hospital or ER, and then continues to receive opioid based treatment. Perhaps there is not communication that the
patient has been treated for an overdose to the prescribing physician, perhaps the patient has made no connection
between the condition for which the opioid treatment is prescribed and the overdose. Perhaps this nonfatal
overdose should represent an opportunity to identify and treat substance use disorders.3
It should be clear that there is a widespread commitment to share drug information with patients, but it is equally
unclear whether the reason for the medication prescription is generally recorded or shared. The prescription label
gives the name of the drug, the dosage and the number of times to take. It does not give an indication of the
purpose served by its taking. Perhaps, there is a need for a Patients Drug Bill of Rights, such as suggested in the N
Engl J Med, July 28, 2016, to provide for safe medication ordering and use the right patient, right drug, right
dose, right time, right route {and the } right indication.
This report is based upon a review of toxicology results and does not include any review of a decedents
prescription history, evidence at the scene (which may be collected by coroners or law enforcement based upon
county protocol), autopsy results, investigatory reports or interviews with next of kin, friends or witnesses.
It is time to search for solutions that recognize the different faces of the drug issue, the addict, the family, those
who will get caught in any broad based, one-size-fits all remedies. As Albert Einstein is quoted to have said,
Insanity is doing the same thing over and over again and expecting different results. No one can be a passive
observer in thinking we can solve this problem by the same thought process which created it.
Patients Continue to Receive Prescription Opioids Following Overdose, MD Magazine, www.hcplive.com
10
Glossary of Drugs
Amphetamines A group of synthetic psychoactive drugs called central nervous system (CNS) stimulants. The collective
group of amphetamines includes amphetamine, dextroamphetamine, and methamphetamine. Methamphetamine is
also known as meth, crank, speed and tina. They may also be found in drugs for ADD or ADHD.
Benzodiazepines A family of sedative-hypnotic drugs indicated for the treatment of stress, anxiety, seizures and
alcohol withdrawal. Benzodiazepines are often referred to as minor tranquilizers. Xanax (Alprazolam) and Valium
(Diazepam) are the most commonly prescribed drugs in this drug class.
Buprenorphine A semi-synthetic opioid known as Buprenex, Suboxone, and Subutex indicated for the treatment of
opioid addiction and moderate to severe pain.
Cathinones - a family of drugs containing one or more synthetic chemicals related to cathinone, an amphetamine-like
stimulant found naturally in the Khat plant. They are 'cousins' of the amphetamine family of drugs, which includes
amphetamine, methamphetamine and MDMA (ecstasy). It often goes by the street name of Molly.
Cannabinoids A series of compounds found in the marijuana plant, the most psychoactive of which is THC, a strong,
illicit hallucinogen. Street names for this drug are often associated with a geographic area from which it came but also
include generic names like ganja, MJ, ragweed, reefer and grass.
Carisoprodol Muscle relaxant indicated for the treatment of pain, muscle spasms and limited mobility. It is often
abused in conjunction with analgesics for enhanced euphoric effect. It is marketed as Soma.
Cocaine An illicit stimulant. Powdered cocaine goes by many street names including C, blow, snow, and nose
candy, while freebase cocaine is mostly commonly known as crack.
Ethanol ethyl alcohol.
Fentanyl Synthetic narcotic analgesic (pain killer) used in the Durgesic transdermal patch. Also available in a solid
lollypop sold under the brand name Actiq.
Flunitrazepam (Rohypnol) Commonly referred to as a date rape drug. It is a sedative-hypnotic drug in the
Benzodiazepine class. It often goes by the street name roofies.
Gamma-Hydroxybutyric Acid (GHB) A depressant, also known as a date rape drug. GHB often goes by the street
name easy lay, scoop, liquid X, Georgia home boy and grievous bodily harm.
Heroin An illicit narcotic derivative. It is a semi-synthetic product of opium. Heroin also has multiple street names
including H, hombre and smack, and others too numerous to mention.
Hydrocodone A narcotic analgesic (pain killer). Vicodin and Lortab are two common drugs containing hydrocodone.
Hydromorphone A narcotic analgesic (pain killer) used to treat moderate to severe pain. Marketed under the trade
name Dilaudid, it is two to eight times more potent than morphine. Commonly used by abusers as a substitute for
heroin.
Ketamine An animal tranquilizer and a chemical relative of PCP. Street names for this drug include special K,
vitamin K and cat valium.
Levamisole-A drug originally developed for use in treating cancer but discontinued for human use due to its negative
effects on the human body. Generally found in the Philadelphia area as a cutting agent for cocaine.
Meperidine A synthetic narcotic analgesic (pain killer) sold under the trade name Demerol, it is used for preanesthesia and the relief of moderate to severe pain.
Methadone A synthetic narcotic analgesic (pain killer) commonly associated with Heroin detoxification and
maintenance programs but it is also prescribed to treat severe pain. It has been increasingly prescribed in place of
oxycodone for pain management. Dolophine is one form of methadone.
Hallucinogenic Phenethylamines/Piperazine Includes such drugs as MDMA (Ecstasy, a hallucinogen), MDA (a
psychedelic), MDEA (a psychedelic hallucinogenic) and Piperazine derivatives. Ecstasy has multiple street names
including E, XTC, love drug, and clarity. MDMA is often also known by a large variety of embossed logos on the
pills such as Mitsubishis and Killer Bees.
Hallucinogenic Tryptamines Natural tryptamines are commonly available in preparations of dried or brewed
mushrooms, while tryptamine derivatives are sold in capsule, tablet, powder, or liquid forms. Street names include
Foxy-Methoxy, alpha-O, and 5-MEO.
Morphine A narcotic analgesic (pain killer) used to treat moderate to severe pain. MS (Morphine Sulfate), Kadian, and
MS-Contin are the tablet forms; Roxanol is the liquid form.
11
Nitrous Oxide (N2O) Also known as "laughing gas," this is an inhalant (gas) that produces light anesthesia and
analgesia. Whippets are a common form of nitrous oxide.
Oxycodone A narcotic analgesic (pain killer). OxyContin is one form of this drug and goes by the street name OC.
Percocet, Percodan, Roxicet, Tylox, and Roxicodone also contain Oxycodone.
Oxymorphone A narcotic analgesic (pain killer), that is often prescribed as Opana, Numorphan and Numorphone.
Phencyclidine (PCP) An illicit dissociative anesthetic/hallucinogen. Common street names for this drug include angel
dust, ace, DOA and wack.
Synthetic Cannabinoids Synthetic cannabinoids are man-made chemicals that are applied (often sprayed) onto plant
material to mimic the effect of delta-9-tetrahydrocannabinol (THC), the psychoactive ingredient in the naturally grown
marijuana plant (cannabis sativa). Synthetic cannabinoids, commonly known as synthetic marijuana, Spice or K2,
are often sold in retail outlets as herbal incense or potpourri, and are labeled not for human consumption.
Sympathomimetic Amines A group of stimulants including phentermine (an appetite suppressant) and other
sympathomimetic amines not tracked elsewhere in this report.
Tramadol A synthetic narcotic analgesic sold under the trade name Ultram and Ultracet. Indications include the
treatment of moderate to severe pain. It is a chemical analogue to Codeine. Not currently a scheduled drug.
Zolpidem A prescription medication used for the short-term treatment of insomnia; it is commonly known as Ambien.
12
Number of Reported Drug Deaths by County, 2015
13
Number of Reported Drug Deaths by Region, 2015
14
Number of Reported Drug Deaths Per 100,000 Population by

County, 2015
15
Change in Number of Reported Drug Deaths from 2014 to 2015

by County
16
Number of Reported Drug Deaths

in Rural and Urban Pennsylvania County, 2015
29.1 per
100,000
22.7 per
100,000
Rural Counties
Urban Counties
Rural Counties
777 Deaths
(22%)
Urban
Counties
2,728 Deaths
(78%)
17
OVERDOSES STATEWIDE BY SPECIFIC DRUGS

OPIOIDS
oxycodone
methadone
dilaudid
morphine
tramadol
fentanyl
buprenorphine
oxymorphone
naloxone
hydromorphone
dihydrocodeine
naltrexone
3%
3% 1%
19%
10%
3%
0%
7%
0%
16%
34%
4%
BENZODIAZEPINES
clonazepam
alprazolam
lorazepam
5%
0%
diazepam
5%
oxazepam
22%
22%
5%
41%
18
midazolam
temazepam
ANTIDEPRESSANTS
3%
4%
doxepin
6%
7%
citalopram
16%
6%
amitriptyline
trazodone
11%
11%
fluoxetine
bupropion
6%
4%
8%
8%
duloxetine
mitazapine
10%
sertraline
ANTIHISTAMINES
1%
5%
6%
diphenhydramine
hydroxyzine
doxylamine
28%
60%
chlorpheniramine
certirizine
ANTIPSYCHOTICS
4% 3%
quetiapine
5%
clonazepine
olanzapine
21%
riperidone
66%
1%
aripiprazone
clozapine
19
ANTICONVULSANTS
topiramate
lamotrigine
phentoin
pregabalin
levetiracetam
dextromethorphan
15%
gababentin
18%
7%
3%
15%
0%
42%
MUSCLE RELAXERS
carisoprodol
cyclobenzaprine
methocarbamol
3%
19%
78%
BARBITUATES
butalbital
HYPNOTICS
phenobarbital
zolpidem
2%
45%
55%
98%
20
zaleplon
ILLEGAL DRUGS
Levamisole
6%
PCP
1%
Acetyl Fentanyl
3%
mCPP
1%
Marijuana
8%
Heroin
55%
Cocaine
26%
DEATHS BY DRUG CLASSIFICATION
Opioids
28%
30%
Benzodiazepines
Antidepessants
Antihistamines
Antipsychotics
Anticonvulsants
Muscle Relaxers
1%
1%
2%
Barbituates
3%
2%
18%
Hypnotics
Illegal Drugs
4%
11%
21
The charts shown on the previous pages show the prevalence of certain drugs, both legally prescribed and those that are
considered to be illegal an having no known medical use for general human consumption. These drugs may have been
legally prescribed for the person whose toxicology was tested or they may have been diverted from their original
prescription holder for use by the end user. Hopefully with the implementation of the PMDP those answers may be
more readily available.
In calculating the drug use by category, it should be noted that heroin was determined to be present when the
Coroner/Medical Examiner listed heroin specifically in the toxicology, when morphine was present with its known
metabolites of 6-monoacetylmorphine or codeine. When morphine was determined to be the only marker of the drug, it
was assumed that morphine was present in that form as it is utilized in hospitals, hospices and other prescriptions. Not
all persons with the drug morphine in their drug toxicology can be presumed to be using heroin without further
evidence, as in its metabolites.
Similarly, it should be noted that amphetamines and methamphetamines were found in 227 instances in the toxicology.
While these stimulants are found in illegal drugs such as meth and MDMA, they are also found in ADD or ADHD drugs.
Therefore, it was not presumed that the presence of the drug was automatically the presence of an illegal form of the
drug.
It should also be noted that 18% of the decedents also had alcohol detected in the toxicology.
22
Statewide Demographics
400
350
300
250
200
150
100
50
0
DEATHS BY TIME OF DAY

1200
1000
800
600
400
200
0
8AM-4PM 4PM-12AM 12AM-8AM
DEATHS BY MONTH
GENDER
DEATHS BY WEEKDAY
600
Male
Female
500
400
300
33%
200
100
0
67%
WEEKDAYS
Sunday
Monday
Tuesday
Thursday
Friday
Saturday
Wednesday
RACE
White
Black
Hispanic
MARITAL STATUS
Asian
Other
Single
Married
0%
13%
Divorced
Widowed
4%
3%
16%
19%
84%
23
61%
1%
0%
AGE
0%
0% 1%
0%
<1
7%
1-4
21%
5-9
10-15
23%
16-19
20-29
30-39
40-49
26%
21%
50-59
60-69
70>
24
ADAMS
HEALTH PROFILE
INCIDENCE OF COMMUNICABLE
DISEASE ASSOCIATED WITH DRUG
USE
DEATHS BY MONTH
3.5
3
2.5
2
1.5
1
0.5
0
Hep B Acute
<5
Hep B Chronic 13
HIV
14
ADMISSIONS FOR SUBSTANCE

ABUSE
Drug Abuse
74
Alcohol Abuse 55
TREATMENT FACILITIES (AS OF 6/13)
DEATHS BY WEEKDAY
3.5
Outpatient
SOURCE: Pennsylvania and County

Health Profiles 2015, PA
Department of Health
2.5
2
1.5
NARCOTIC TREATMENT PROGRAMS
1
0.5
0
Sunday
Monday
Tuesday Wednesday Thursday
Friday
Saturday
METHADONE CLINICS None

Physicians authorized to prescribe
buprenorphine
6
SOURCE: PA DDAP 2015, SAMSHA
July 2016

5
PROBLEM SOLVING COURTS
None
3
2
SOURCE: PA Unified Judicial System

June 2016
1
0
8AM-4PM
4PM-12AM
12AM-8AM
25
DRUG RELATED DEATHS

2015 10
2014 <10
GENDER
AGE
10%
10%
Female
30%
20-29
10%
30-39
20%
40-49
Male
70%
50-59
60-69
50%
Female
MARITAL STATUS
30%
Single
40%
Married
Divorced
30%

Opioids
Benzodiazepines
20%
35%
3%
Antidepressants
Antihistamines
8%
Antipsychotics
3%
2%
Anticonvulsants
17%
Muscle Relaxers
12%
Illegal
26
Male
ALLEGHENY
HEALTH PROFILE
DEATHS BY TIME
USE
200
150
Hep B Acute
24
Hep B Chronic 304
HIV
378
100
50

ABUSE
0
8AM-4PM
4PM-12AM
12AM-8AM
Drug Abuse
3,301
Alcohol Abuse 1,428
DEATHS BY WEEKDAY
Inpatient non-hospital
Inpatient hospital
Partial Hospitalization
Outpatient
80
70
60
50
40
30
20
10
0
16
1
21
54

Sunday
Monday
Friday
Saturday
METHADONE CLINICS 6
buprenorphine
180
Centers of Excellence 2
DEATHS BY MONTH

July 2016, PA DHS July 2016
60
50
40
30
20
Adult Drug Court

Veterans Court
10
0

June 2016
27
DRUG RELATED DEATHS

2015 414
2014 302
GENDER
Female
RACE
Male
White
Black
13%
29%
71%
87%
Opioids
Benzodiazepines
33%
Anticonvulsants
Antidepressants
45%
Muscle Relaxers
Antihistamines
Antipsychotics
Barbituates
Hypnotics
12%
7%
1%
0%
0%
0%
1%
1%
28
Illegal
ARMSTRONG
HEALTH PROFILE
USE
12
10
8
6
Hep B Acute
0
Hep B Chronic 5
HIV
5
4
2
0
8AM-4PM
4PM-12AM
12AM-8AM
ADMISSIONS FOR SUBTANCE ABUSE

Drug Abuse
221
Alcohol Abuse 163
DEATHS BY WEEKDAY
Inpatient Non-hospital 2
Partial Hospitalization 1
Outpatient
4
10
8
6

4
2
0

METHADONE CLINICS 1
buprenorphine
3
DEATHS BY MONTH

July 2016
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
None
June 2016
DRUG RELATED DEATHS
2015 28
2014 17
29
AGE
10-15
20-29
30-39
7%
GENDER
40-49
50-59
60-69
Female
Male
4%
11%
15%
33%
15%
67%
48%
MARITAL STATUS
Single
Married
Divorced
22%
37%
41%

Opioids
Benzodiazepines
18%
Antidepressants
4% 1%
1%
41%
5%
Muscle Relaxers
Antihistamines
12%
Barbituates
18%
Hypnotics
Illegal
30
BEAVER
HEALTH PROFILE
USE
20
15
Hep B Acute
<5
Hep B Chronic 16
HIV
17
10
5
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
405
Alcohol Abuse 234
DEATHS BY WEEKDAY
Outpatient
6
10
8

6
4
2
0

METHADONE CLINICS 2
buprenorphine
12
July 2016
DEATHS BY MONTH
7
6
5
4
3
2
1
0
Veterans Court
June 2016
DRUG RELATED DEATHS
2015
31
35
AGE
RACE
3% 3%
13%
10-15
20%
16-19
26%
8%
20-29
White
30-39
Black
40-49
50-59
87%
40%
GENDER
MARITAL STATUS
5%
40%
Single
28%
Female
Married
Male
Divorced
60%
67%
DEATH BY DRUG CLASSIFICATION

Opioids
Benzodiazepines
35%
47%
Antidepressants
Antihistamines
Muscle Relaxers
Hypnotics
1%
1%
1%
3%
Illegal
12%
32
BEDFORD
HEALTH PROFILE
In the effort to maintain best practices in de-identifying personal and
potentially health related data, any quantification of the drug related deaths
by age, gender, race, drugs and date is not provided. The complete data though
is included in the calculation of the state-wide statistics.
USE
Hep B Acute
<5
Hep B Chronic 7
HIV
6

ABUSE
Drug Abuse
95
Alcohol Abuse 65
Outpatient

buprenorphine
2
July 2016
None
June 2016
DRUG RELATED DEATHS
2015
2014
33
<10
<10
BERKS
HEALTH PROFILE
DEATHS BY TIME
12
10
USE
8
6
Hep B Acute
<5
Hep B Chronic 184
HIV
101
4
2
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
922
Alcohol Abuse 565
DEATHS BY MONTH
14
12
10
8
6
4
2
0

Outpatient
11
METHADONE CLINICS 1
buprenorphine
23
DEATHS BY MONTH
14
12
10
8
6
4
2
0


Adult Drug Court
Veterans Court
June 2016
DRUG RELATED DEATHS
34
2015
2014
69
64
AGE
2%
GENDER
2%
3%
<1
4%
16-19
17%
20-29
29%
43%
30-39
40-49
23%
Female
Male
57%
50-59
60-69
20%
70>
RACE
MARITAL STATUS
6%
19%
1%
Single
20%
White
Married
Black
51%
Hispanic
Widowed
23%
80%

Opioids
Benzodiazepines
22%
29%
2%
Antidepressants
Muscle Relaxers
2%
Antihistamines
1%
Anticonvulsants
2%
Antipschotics
2%
1%
19%
20%
Barbituates
Hypnotics
Illegal
35
Divorced
BLAIR
HEALTH PROFILE
DEATHS BY TIME
USE
10
8
6
Hep B Acute
<5
Hep B Chronic 18
HIV
9
4
2
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
473
Alcohol Abuse 275
DEATHS BY WEEKDAY
Inpatient Non-hospitalization
Outpatient
10
8
6
4
5
4
9

Health Profiles 2015, PA Department
of Health
2
0

METHADONE CLINICS 2
buprenorphine
13
DEATHS BY MONTH
10
8
Adult Drug Court

Juvenile Drug Court
Family Drug
Re-entry Drug
4
2
0

June 2016
36
DRUG RELATED DEATHS

2015 38
2014 21
AGE
5%
GENDER
13%
20-29
26%
37%
30-39
Female
40-49
Male
50-59
37%
63%
60-69
19%
MARITAL STATUS
4%
12%
Single
Married
17%
Divored
67%
Widowed

Opioids
19%
Benzodiazepines
2%
40%
3%
1%
Antidepressants
Muscle Relaxers
11%
Antihistamines
Anticonvulsants
Illegal
24%
37
BRADFORD
HEALTH PROFILE
DEATHS BY TIME
USE
7
6
5
Hep B Acute
0
Hep B Chronic 9
HIV
5
4
3
2
1
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
100
Alcohol Abuse 84
DEATHS BY WEEKDAY
Outpatient
3
5
4

of Health
3
2
1
0
Sunday
Monday
Friday
DEATHS BY MONTH
Saturday

buprenorphine
1
July 2016
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
Adult Drug Court (hybrid)

June 2016
DRUG RELATED DEATHS
2015
2014
38
16
11
AGE
GENDER
Female
6%
19%
Male
20-29
30-39
6%
38%
37%
40-49
50-59
31%
63%
60-69
MARITAL STATUS
33%
34%
Single
Married
Divorced
33%

Opioids
Benzodiazepines
Antidepressants
Muscle Relaxers
Antihistamines
Antipsychotics
Anticonvulsants
Illegal
15%
30%
3%
2%
5%
5%
17%
23%
39
BUCKS
HEALTH PROFILE
DEATHS BY WEEKDAY
USE
6
5
4
Hep B Acute
9
Hep B Chronic 295
HIV
126
3
2
1
0
Sunday
Monday
Friday
Saturday

ABUSE
Drug Abuse
1,174
Alcohol Abuse 355
DEATHS BY MONTH
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0

Outpatient
20
of Health
AGE
20-29
30-39
40-49
50-59
60-69
70>
METHADONE CLINICS 3
buprenorphine
47
7% 2%
28%
23%
Adult Drug Court

June 2016
12%
28%
40
DRUG RELATED DEATHS

2015 123
2014 205*(Included MVA,
Homicides, Natural Deaths where
drugs were found in the toxicology)
GENDER
Female
Male
38%
62%

Opioids
Benzodiazepines
Antidepressants
Muscle Relaxers
Antihistamines
Antipsychotics
Anticonvulsants
Illegal
39%
44%
3%
1%
2%
2%
5%
41
4%
BUTLER
HEALTH PROFILE
DEATH BY TIME
20
USE
15
10
5
0
8AM-4PM
4PM-12AM
12AM-8AM
Hep B Acute
5
Hep B Chronic 21
HIV
14

ABUSE
DEATHS BY WEEKDAY
10
Drug Abuse
358
Alcohol Abuse 146
8
6
4
2
Inpatient Non-hospital
Inpatient hospital
Outpatient
3
1
2
8

of Health
DEATHS BY MONTH
10
8
6
4
2
0

METHADONE CLINICS 2
buprenorphine
87
July 2016
AGE
20-29
30-39
40-49

50-59
60-69
Adult Drug Court

Veterans Court
8%
4%

June 2016
31%
15%
DRUG RELATED DEATHS

2015 48
2014 33
42%
42
MARITAL STATUS
GENDER
Single
Married
Divorced
2%
15%
33%
Female
12%
Male
67%
71%

Opioids
Benzodiazepines
Antidepressants
Anticonvulsants
Muscle Relaxers
Antihistamines
Hypnotics
Illegal
26%
33%
1%
4%
2%
2%
13%
19%
43
Widowed
CAMBRIA
HEALTH PROFILE
DEATHS BY TIME
USE
20
15
Hep B Acute
<5
Hep B Chronic 28
HIV
17
10
5
0
8AM-4PM
4PM-12AM

ABUSE
12AM-8AM
Drug Abuse
604
Alcohol Abuse 215
DEATHS BY WEEKDAY

Outpatient
7
Saturday
Friday
Thursday
Wedneday

of Health
Tuesday
Monday
Sunday

0
10
12
14
METHADONE CLINICS 1
buprenorphine
12
DEATHS BY MONTH

November
September
July
Veterans Court
May
March
January
0
10
12

June 2016
DRUG RELATED DEATHS
44
2015
2014
57
37
AGE
GENDER
2%
6%
14%
16-19
16%
20-29
30-39
Female
49%
51%
40-49
23%
Male
50-59
39%
60-69
RACE
MARITAL STATUS
2%
9%
Single
27%
White
Black
10%
Married
61%
Widowed
91%

Opioids
Benzodiazepines
18%
Antidepressants
2%
36%
1%
6%
Anticonvulsants
Antihistamines
2%
Muscle Relaxers
1%
18%
Barbituates
16%
Hypnotics
Illegal
45
Divorced
CAMERON
HEALTH PROFILE
In the effort to maintain best practices in de-identifying personal and potentially
health related data, any quantification of the drug related deaths by age,
gender, race, drugs and date is not provided. The complete data though is
included in the calculation of the state-wide statistics.
USE
Hep B Acute
<5
Hep B Chronic <5
HIV
0

ABUSE
Drug Abuse
36
Alcohol Abuse 17
Outpatient

of Health
buprenorphine
1
July 2016
None
June 2016
DRUG RELATED DEATHS
2015
2014
46
<10
0
CARBON
HEALTH PROFILE
WEEKDAY
USE
6
5
4
3
2
1
0
Hep B Acute
<5
Hep B Chronic 8
HIV
12

ABUSE
Drug Abuse
274
Alcohol Abuse 106
MONTH
5
4
Outpatient
3
2

of Health
1
0

buprenorphine
6
AGE
16-19
20-29
13%
30-39
50-59

July 2016
6%

None
44%

June 2016
37%
DRUG RELATED DEATHS

2015
2014
47
18
17
GENDER
MARITAL STATUS
Female
Single
Male
Married
Divorced
6%
31%
19%
69%
75%

Opioids
Benzodiazepines
Antidepressants
Muscle Relaxers
Antihistamines
Antipsychotics
Anticonvulsants
Illegal
12%
34%
22%
8%
2%
2%
16%
4%
48
CENTRE
DEATHS BY WEEKDAY
HEALTH PROFILE
6
5
USE
4
3
2
1
Hep B Acute
<5
Hep B Chronic 104
HIV
18

ABUSE
Drug Abuse
218
Alcohol Abuse 313
DEATHS BY MONTH
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
Inpatient Non-Hospital 1
Outpatient
9
of Health
METHADONE CLINICS 1
buprenorphine
16
Centers of Excellence
(Lycoming/Tioga/Clinton/Centre)
AGE
20-29
30-39
40-49

July 2016
50-59

23%
None
June 2016
53%
6%
18%
DRUG RELATED DEATHS

2015 17
2014 18
49
GENDER
MARITAL STATUS
Female
Single
Male
Married
Divorced
19%
41%
19%
59%

Opioids
Benzodiazepines
Antidepressants
Antipsychotics
Anticonvulsants
Illegal
Antihistamines
23%
34%
4%
4%
8%
8%
19%
50
62%
CHESTER
HEALTH PROFILE
DEATHS BY TIME
USE
60
50
40
Hep B Acute
<5
Hep B Chronic 149
HIV
85
30
20
10
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
559
Alcohol Abuse 590
DEATHS BY WEEKDAY
30
25
20
15
10
5
0
Outpatient
16
of Health
METHADONE CLINICS 2
buprenorphine
28
DEATHS BY MONTH

July 2016
20
15
10
Adult Drug Court

Veterans Court
5
0

June 2016
DRUG RELATED DEATHS
2015 131
2014 82
51
AGE
16-19
20-29
30-39
GENDER
40-49
5% 4%
14%
50-59
60-69
70>
Female
Male
11%
31%
15%
69%
34%
17%
MARITAL STATUS
Single
Married
Divorced
RACE
Widowed
White
7%
Black
Hispanic
7%
8%
25%
40%
85%
28%

Opioids
Benzodiazepines
Antidepressants
Anticonvulsants
Antihistamines
Antipsychotic
Muscle Relaxers
Hypnotic
Illegal
19%
25%
1% 0%
1%
6%
6%
19%
23%
52
CLARION
HEALTH PROFILE
USE
Hep B Acute
<5
Hep B Chronic <5
HIV
4

ABUSE
Drug Abuse
133
Alcohol Abuse 92
Outpatient
1
of Health
buprenorphine
2
July 2016
Adult Drug Court (Hybrid)

June 2016
DRUG RELATED DEATHS
2015 <10
2014 <10
53
CLEARFIELD
HEALTH PROFILE
DEATHS BY TIME
USE
5
4
3
Hep B Acute
<5
Hep B Chronic 49
HIV
3
2
1
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
212
Alcohol Abuse 104
DEATHS BY WEEKDAY
5
4
3
2
1
0
Outpatient

of Health
METHADONE CLINICS 1
buprenorphine
3
DEATHS BY MONTH

July 2016
2.5
2
1.5
1
0.5
0

Adult Drug Court
Juvenile Drug Court
June 2016
DRUG RELATED DEATHS
2015 14
2014 15
54
AGE
20-29
30-39
GENDER
40-49
50-59
60-69
Female
Male
8%
23%
23%
38%
62%
23%
23%

Opioids
Benzodiazepines
Antidepressants
Antihistamines
Anticonvulsants
Illegal
2%
Muscle Relaxers
5%
14%
42%
2%
12%
23%
55
CLINTON
HEALTH PROFILE
USE
Hep B Acute
0
Hep B Chronic 5
HIV
3

ABUSE
Drug Abuse
64
Alcohol Abuse 40
Outpatient

of Health
buprenorphine
4
July 2016
June 2016
DRUG RELATED DEATHS
2015
2014
56
<10
<10
COLUMBIA
DEATHS BY TIME
HEALTH PROFILE
6.5
6
USE
5.5
5
4.5
8AM-4PM
4PM-12AM
12AM-8AM
Hep B Acute
<5
Hep B Chronic 15
HIV
10

ABUSE
DEATHS BY WEEKDAY
5
Drug Abuse
92
Alcohol Abuse 34
4
3
Outpatient
1
0
Sunday
Monday
Friday
DEATHS BY MONTH
Saturday

of Health
3.5
3
2.5
2
1.5
1
0.5
0

buprenorphine
3
July 2016
Adult Drug Court
(Columbia/Montour)
AGE
20-29
30-39
25%
40-49

June 2016
50-59
19%
DRUG RELATED DEATHS

2015
25%
31%
57
16
GENDER
MARITAL STATUS
Female
Single
Male
Married
Divorced
19%
40%
60%
25%
56%

Opioids
Benzodiazepines
Antidepressants
Antihistamines
Muscle Relaxers
Antipsychotics
4%
4%
10%
29%
11%
17%
25%
58
Anticonvulsants
CRAWFORD
HEALTH PROFILE
AGE
16-19
20-29
30-39
40-49
50-59
60-69
USE
4% 3%
Hep B Acute
0
Hep B Chronic 14
HIV
10
21%
29%

ABUSE
7%
36%
Drug Abuse
150
Alcohol Abuse 181
GENDER
Female
Outpatient
Male

of Health
36%
64%

METHADONE CLINICS 1
buprenorphine
6

Opioids
Antidepressants
Antihistamines
Illegal

July 2016
None
43%
42%

June 2016
DRUG RELATED DEATHS
3%
2015
2014
12%
59
28
16
CUMBERLAND
HEALTH PROFILE
DEATHS BY TIME
USE
20
15
10
5
0
8AM-4PM
4PM-12AM
12AM-8AM
Hep B Acute
<5
Hep B Chronic 97
HIV
34

ABUSE
Drug Abuse
302
Alcohol Abuse 247
DEATHS BY WEEKDAY
12
10
8
6
4
2
0

Outpatient
9
of Health
METHADONE CLINICS 1
buprenorphine
9
DEATHS BY MONTH

July 2016
10
8
6
4
2

June 2016
DRUG RELATED DEATHS
2015 41
2014 35
60
GENDER
AGE
16-19
20-29
30-39
40-49
50-59
60-69
Female
70>
Male
3%
5%2%
17%
31%
32%
17%
69%
24%
MARITAL STATUS
Single
RACE
White
Married
Hispanic
Divorced
10%
13%
2%
12%
98%

Opioids
Benzodiazepines
Antidepressants
Antihistamines
Barbituates
Illegal
33%
42%
2%
2%
4%
17%
61
65%
Widowed
DAUPHIN
HEALTH PROFILE
USE
DEATHS BY WEEKDAY
Hep B Acute
<5
Hep B Chronic 196
HIV
130
20
15
10

ABUSE
5
0
Drug Abuse
473
Alcohol Abuse 224
Outpatient
14
of Health
DEATHS BY MONTH
15
10
METHADONE CLINICS 1
buprenorphine
12
5
0

Veterans Court
June 2016
DRUG RELATED DEATHS
2015
2014
62
82
54
AGE
20-29
30-39
40-49
GENDER
50-59
60-69
Female
Male
10%
24%
34%
19%
66%
21%
26%
RACE
White
Black
Hispanic
MARITAL STATUS
Asian
Single
1%
3%
13%
Married
15%
28%
57%
83%

Opioids
Benzodiasepines
Antidepressants
Anticonvulsants
Muscle Relaxers
Antihistamines
Hypnotics
Illegal
32%
34%
1%
4%
2%
4%
6%
63
17%
Divorced
DELAWARE
DEATHS BY TIME
HEALTH PROFILE
100
80
USE
60
40
20
0
8AM-4PM
4PM-12AM
12AM-8AM
DEATHS BY WEEKDAY
Hep B Acute
5
Hep B Chronic 685
HIV
259

ABUSE
40
30
20
10
0
Drug Abuse
1,212
Alcohol Abuse 349
Outpatient
19
DEATHS BY MONTH
30
25
20
15
10
5
0

of Health
METHADONE CLINICS 2
buprenorphine
60
AGE
16-19
20-29
30-39
40-49
50-59
60-69
70>
1%
6% 2%


21%
Adult Drug Court

Veterans Court
23%

June 2016
27%
20%
DRUG RELATED DEATHS

64
2015
2014
208
149
RACE
GENDER
Female
White
Male
Black
Hispanic
0%
9%1%
28%
72%
90%
MARITAL
Single
Married
11%
Divorced
Widowed
4%
15%
70%

Opioids
Benzodiazepines
Anticonvulsants
Antidepressants
Antihistamines
Barbituates
Hypnotics
Illegal
26%
38%
0%
1%
2%
2%
4%
2%
25%
65
Muscle Relaxers
Asian
ELK
HEALTH PROFILE
health related data, any quantification of the drug related deaths by age, gender,
race, drugs and date is not provided. The complete data though is included in the
calculation of the state-wide statistics.
USE
Hep B Acute
<5
Hep B Chronic <5
HIV
0

ABUSE
Drug Abuse
74
Alcohol Abuse 36
TREATMENT FACILITIES (AS OF
6/13)
Outpatient
SOURCE: Pennsylvania and

County Health Profiles 2015, PA
NARCOTIC TREATMENT
PROGRAMS
buprenorphine
2

July 2016

None
SOURCE: PA Unified Judicial
System June 2016
DRUG RELATED DEATHS
66
2015
2014
<10
<10
ERIE
HEALTH PROFILE
USE
DEATHS BY WEEKDAY
Hep B Acute
<5
Hep B Chronic 58
HIV
35
16
14
12

ABUSE
10
8
Drug Abuse
693
Alcohol Abuse 403
6
4
2
Inpatient Hospital
Outpatient
6
2
1
16

of Health
DEATHS BY MONTH
14
12
METHADONE CLINICS 2
buprenorphine
23
10
8
6
4

2
0

Adult Drug Court
Family Drug Court
Veterans Court
June 2016
67
DRUG RELATED DEATHS

2015 68
2014 60
AGE
1-5
16-19
20-29
30-39
40-49
50-59
60-69
70>
GENDER
3%3%3%1%
Female
Male
24%
22%
32%
68%
18%
26%

Opioids
Benzodiazepines
Anticonvulsants
Antidepressants
Muscle Relaxers
Antihistamines
Antipsychotics
Barbituates
Hypnotics
Illegal
26%
28%
1%
2%
0%
4%
1%
13%
4%
21%
68
FAYETTE
HEALTH PROFILE
DEATHS BY TIME
USE
25
20
15
Hep B Acute
<5
Hep B Chronic 13
HIV
16
10
5
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
386
Alcohol Abuse 320
DEATHS BY WEEKDAY
10
8
6
4
2
0
Outpatient
6
of Health
METHADONE CLINICS 2
buprenorphine
12
DEATHS BY MONTH
10
8
6
4
2
0

July 2016
Veterans Court
June 2016
DRUG RELATED DEATHS
2015
2014
69
40
40
AGE
20-29
30-39
GENDER
40-49
8%
50-59
60-69
Female
Male
17%
32%
25%
22%
68%
28%
MARITAL
Single
Married
Divorced
30%
47%
23%

Opioids
Benzodiazepines
Anticonvulsants
Antidepressants
Muscle Relaxers
Antihistamines
Barbituates
Illegal
26%
38%
1%
8%
4%
13%
4%
70
6%
FOREST
HEALTH PROFILE
USE
Hep B Acute
0
Hep B Chronic 11
HIV
1

ABUSE
Drug Abuse
15
Alcohol Abuse 8
Inpatient Non- Hospital 1
Outpatient
2
of Health
buprenorphine
None
July 2016
Adult Drug Court

Juvenile Drug Court
June 2016
DRUG RELATED DEATHS
2015
2014
71
<10
0
FRANKLIN
HEALTH PROFILE
DEATHS BY WEEKDAY
USE
6
5
4
3
2
1
0
Hep B Acute
<5
Hep B Chronic 21
HIV
18

ABUSE
Drug Abuse
161
Alcohol Abuse 168
DEATHS BY MONTH
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
Outpatient
7
of Health
buprenorphine
8
July 2016
AGE
10-15
20-29
14%
30-39
40-49
50-59
None
5%
19%

June 2016
24%
DRUG RELATED DEATHS

2015
2014
38%
72
21
14
RACE
GENDER
White
Female
Male
6%
48%
52%
94%
MARITAL STATUS
Single
Married
Divorced
Widowed
5%
14%
48%
33%

Opioids
Benzodiazepines
Anticonvulsants
Muscle Relaxers
Antipsychotic
Illegal
23%
27%
2%
1%
17%
21%
9%
73
Antidepressants
Black
FULTON
HEALTH PROFILE
USE
Hep B Acute
<5
Hep B Chronic 0
HIV
1

ABUSE
Drug Abuse
41
Alcohol Abuse 19
Outpatient

of Health
buprenorphine
1
July 2016
None
June 2016
DRUG RELATED DEATHS
2015
74
<10
GREENE
HEALTH PROFILE
WEEKDAY
3.5
3
USE
2.5
2
1.5
Hep B Acute
<5
Hep B Chronic 26
HIV
15
1
0.5
0

ABUSE
Drug Abuse
240
Alcohol Abuse 167
MONTH
3.5
Outpatient
4
3
2.5

of Health
2
1.5
1
0.5
0

buprenorphine
2
July 2016
AGE
None
14%
20-29
14%
30-39
21%
40-49
22%
50-59

June 2016
DRUG RELATED DEATHS
60-69
29%
2015
2014
75
14
10
MARITAL STATUS
GENDER
29%
43%
43%
Female
Married
Male
57%
Single
Divorced
28%
17%
Opioids
2%
34%
2%
Benzodiazepines
Antidepressants
4%
Anticonvulsants
4%
Muscle Relaxers
Antihistamines
Barbituates
15%
Illegal
22%
76
HUNTINGTON
HEALTH PROFILE
USE
DEATHS BY TIME
6
5
4
3
2
1
0
Hep B Acute
0
Hep B Chronic <5
HIV
2

ABUSE
8AM-4PM
4PM-12AM
12AM-8AM
Drug Abuse
66
Alcohol Abuse 39
Outpatient
DEATHS BY WEEKDAY

of Health
5
4
3
2
1
0

buprenorphine
2
July 2016
DEATHS BY MONTH
None
4
3
2
1
0

June 2016
DRUG RELATED DEATHS
2015
2014
77
10
<10
AGE
20%
GENDER
10%
20-29
10%
10%
10%
Single
40-49
40%
50-59
Female
20%
20%
Male
60%
60-69
50%
MARITAL STATUS
50%
Married
Divorced
Widowed
70>

17%
33%
Opioids
Benzodiazepines
Antihistamines
22%
Antidepressants
Illegal
11%
17%
78
INDIANA
HEALTH PROFILE
DEATHS BY TIME
USE
15
10
Hep B Acute
0
Hep B Chronic 27
HIV
6
5
0
8AM-4PM
4PM-12AM
12M-8AM

ABUSE
Drug Abuse
334
Alcohol Abuse 260
DEATHS BY WEEKDAY
Outpatient
5
10
8
6
4
2
0

of Health
METHADONE CLINICS 1
buprenorphine
11
July 2016
DEATHS BY MONTH
8
6
4
2
0

Adult Drug Court

June 2016
DRUG RELATED DEATHS
2015 36
2014 10
79
MARITAL STATUS
AGE
3%
3%
8%
14%
GENDER
<1
3%
16-19
11%
Single
20-29
28%
Female
36%
64%
40-49
33%
Married
33%
30-39
53%
Male
50-59
Widowed
11%
60-69

Opioids
18%
1%
1%
Benzodiazepines
32%
1%
Antidepressants
Anticonvulsants
10%
Muscle Relaxers
Antihistamines
8%
29%
Hypnotics
Illegal
80
Divorced
JEFFERSON
HEALTH PROFILE
USE
Hep B Acute
0
Hep B Chronic <5
HIV
0

ABUSE
Drug Abuse
139
Alcohol Abuse 70
Outpatient

of Health
buprenorphine
2
July 2016
None

June 2016
DRUG RELATED DEATHS

2015
81
<10
JUNIATA
HEALTH PROFILE

USE
Hep B Acute
0
Hep B Chronic <5
HIV
1

ABUSE
Drug Abuse
7
Alcohol Abuse 3
Outpatient

of Health
buprenorphine
2
July 2016
None
June 2016
DRUG RELATED DEATHS
2015
82
<10
LACKAWANNA
HEALTH PROFILE
AGE
3%
20%
USE
20-29
14%
30-39
40-49
22%
41%
Hep B Acute
<5
Hep B Chronic 71
HIV
43
50-59
60-69

ABUSE
GENDER
Drug Abuse
524
Alcohol Abuse 406
31%
69%
Female
Male
Ipatient Non-hospital 2
Outpatient
7
DEATHS BY DRUG CLASSIFICATION*

1%

of Health
11%
Opioids
Anticonvulsants
12%
Benzodiazepines
48%
Antidepressants
Antihistamines
24%
Illegal
4%
METHADONE CLINICS 1
buprenorphine
15

Adult Drug Court
Juvenile Drug Court
Family Drug Court
Co-occurring Court
Veterans Court
*Drug listings incomplete.
83

June 2016
DRUG RELATED DEATHS
2015 74
2014 30
LANCASTER
HEALTH PROFILE
DEATHS BY WEEKDAY
USE
20
15
10
Hep B Acute
<5
Hep B Chronic 224
HIV
104
5
0

ABUSE
Drug Abuse
1,352
Alcohol Abuse 899
DEATHS BY MONTH
12
10
8
6
4
2
0

Outpatient
20
of Health
AGE
16-19
20-29
30-39
40-49
50-59
60-69
70>
5% 3%2%
24%
METHADONE CLINICS 1
buprenorphine
28
25%

Adult Drug Court
Juvenile Drug Court
17%
24%

June 2016
DRUG RELATED DEATHS
84
2015
2014
80
56
RACE
MARITAL STATUS
Single
Married
Divorced
White
Widowed
Black
Hispanic
17%
2%
18%
10%
17%
63%
73%

Opioids
Benzodiazepines
Antidepressants
Muscle Relaxers
Antihistamines
Illegal
Anticonvulsants
19%
3%
1%
3%
50%
11%
13%
85
LAWRENCE
HEALTH PROFILE
USE
DEATHS BY WEEKDAY
8
6
Hep B Acute
<5
Hep B Chronic 13
HIV
7
4
2
0

ABUSE
Drug Abuse
439
Alcohol Abuse 193
DEATHS BY MONTH
Outpatient
5
5
4
3
2
1
0

of Health
METHADONE CLINICS 1
buprenorphine
9
July 2016
AGE
20-29
30-39
40-49
50-59

17%
Adult Drug Court
27%

June 2016
33%
23%
DRUG RELATED DEATHS

2015
86
30
RACE
GENDER
Female
White
Male
Black
17%
27%
73%
83%

Opioids
Benzodiazepines
Antidepressants
Hypnotics
38%
46%
1%
2%
13%
87
Illegal
LEBANON
HEALTH PROFILE
USE
DEATHS BY WEEKDAY
7
Hep B Acute
0
Hep B Chronic 34
HIV
23
6
5
4

ABUSE
Drug Abuse
249
Alcohol Abuse 140
2
1
0
Sunday
Monday
Friday
Saturday
Outpatient
4
of Health
DEATHS BY MONTH
METHADONE CLINICS 2
buprenorphine
4
7
6
5

July 2016
4
3
2
Adult Drug Court

June 2016
DRUG RELATED DEATHS
2015
2014
88
20
15
AGE
20-29
30-39
40-49
50-59
20%
10%
50%
20%
GENDER
Female
Male
30%
70%

Opioids
Benzodiazepines
Antidepressants
Antihistamines
Hypnotics
Anticonvulsants
Barbituates
Illegal
21%
40%
8%
2%
2%
19%
4% 4%
89
LEHIGH
HEALTH PROFILE

60
USE
50
40
30
Hep B Acute
8
Hep B Chronic 276
HIV
135
20
10
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
708
Alcohol Abuse 313
DEATHS BY MONTH
15
10
Inpatient Non-Hospitalization
Outpatient
14
5
0

METHADONE CLINICS 1
buprenorphine
12
Centers of Excelence 1
DEATHS BY WEEKDAY
25

July 2016
20
15
10
None

May 2016
DRUG RELATED DEATHS
90
2015
2014
115
88
AGE
RACE
4%
10 - 15
4%
1%
22%
27%
24%
100
16 - 19
80
20 - 29
18%
30 - 39
60
40 - 49
40
50 - 59
20
60 - 69
0
White
Black
MARITAL STATUS
17%
GENDER
4%
Single
37%
Married
17%
Hispanic
62%
Divorced
63%
Widowed
DEATHS BY DRUG CATEGORY

Stimulants
10% OTC
2%
Hypnotics
1%
Opioids
17%
Illegal
20%
Barbituates
0%
Antipsychotics
4%
Antihistamines
Muscle Relaxers
6%
2%
Anticonvulsants
7%
Benzodiazepines
16%
Antidepressants
15%
91
Female
Male
LUZERNE
HEALTH PROFILE
USE
DEATHS BY WEEKDAY
25
Hep B Acute
31
Hep B Chronic 118
HIV
51
20
15

ABUSE
10
5
Drug Abuse
439
Alcohol Abuse 246

Sunday
Monday
Friday
DEATHS BY MONTH
Saturday
Inpatient Hospital
Outpatient
7
1
4
10

of Health
16
14
12
10
METHADONE CLINICS 2
buprenorphine
38
8
6
4
2


Adult Drug Court
June 2016
DRUG RELATED DEATHS
92
2015
2014
96
67
AGE
10-15
16-19
20-29
30-39
40-49
50-59
60-69
70>
1%
2%
4%1%
21%
25%
27%
19%
GENDER
Female
Male
29%
71%

Opioids
Benzodiazepines
Antidepressants
Anticonvulsants
Muscle Relaxers
Antihistamines
Antipsychotics
Illegal
30%
40%
1%
2%1%
1% 4%
21%
93
LYCOMING
HEALTH PROFILE
USE

15
Hep B Acute
<5
Hep B Chronic 26
HIV
15
10
DEATHS

ABUSE
0
8AM - 4PM 4PM - 12AM 12AM-8AM
Drug Abuse
240
Alcohol Abuse 167
TREATMENT FACILITIES (AS OF
6/13)
DEATHS BY MONTH
6
4
Outpatient
4
2
0

NARCOTIC TREATMENT
PROGRAMS
METHADONE CLINICS 1
buprenorphine 14
DEATHS BY WEEKDAY
8
6
4
2
0

July 2016
Adult Drug Court
Juvenile Drug Court
June 2016
94
DRUG RELATED DEATHS

2015 25
2014 13
MARITAL STATUS
DEATHS BY DRUG CATEGORY

Single
Married
Divorced
Widowed
9%
Opioids
Anticonvulsants
1%
17%
Benzodiazepines
7%
Antidepressants
29%
18%
57%
Muscle Relaxers
17%
Antihistamines
0% 1%
6%
2%
Antipsychotics
3%
7%
15%
Barbituates
Hypnotics
11%
Illegal
GENDER
OTC
Stimulants
36%
64%
Male
Female
AGE
20 - 29
8%4%
24%
RACE
30 - 39
30
40 - 49
20%
20%
24%
50 - 59
25
60 - 69
20
70>
15
10
5
0
White
95
Black
MCKEAN
HEALTH PROFILE
USE
Hep B Acute
<5
Hep B Chronic <5
HIV
5

ABUSE
Drug Abuse
154
Alcohol Abuse 165
Inpatient Hospital
1
Outpatient
5
of Health
buprenorphine
2
July 2016
None
June 2016
DRUG RELATED DEATHS
2015
2014
96
<10
<10
MERCER
HEALTH PROFILE
USE
DEATHS BY TIME
Hep B Acute
<5
Hep B Chronic 17
HIV
8
8
6
4

ABUSE
2
0
8AM-4PM
4PM-12AM
12AM-8AM
Drug Abuse
143
Alcohol Abuse 118
DEATHS BY WEEKDAY

Outpatient
6
8
6
4
2
0

of Health
METHADONE CLINICS 1
buprenorphine
12
July 2016
DEATHS BY MONTH
5
4
3
2
1
0
Veterans Court
June 2016
DRUG RELATED DEATHS
2015
2014
97
19
27
AGE
20-29
30-39
GENDER
40-49
50-59
60-69
Female
Male
11%
16%
37%
37%
63%
26%
10%
MARITAL STATUS
Single
Married
Divorced
Widowed
RACE
11%
17%
White
44%
Black
11%
28%
89%

Opioids
Benzodiazepines
Antidepressants
Muscle Relaxers
Barbituates
Illegal
30%
34%
2%
3%
15%
16%
98
MIFFLIN
HEALTH PROFILE
USE
Hep B Acute
0
Hep B Chronic 7
HIV
3

ABUSE
Drug Abuse
23
Alcohol Abuse 25
Outpatient
1
of Health
buprenorphine
6
July 2016
Juvenile Drug Court
June 2016
DRUG RELATED DEATHS
2015
2014
99
<10
<10
MONROE
HEALTH PROFILE
USE
WEEKDAY
Saturday
Hep B Acute
<5
Hep B Chronic 90
HIV
41
Friday
Thursday
Wednesday

ABUSE
Tuesday
Monday
Drug Abuse
186
Alcohol Abuse 82
Sunday
0
10
12

Inpatient Nonhospital 1
Outpatient
8
DEATHS BY MONTH
Novemer

of Health
September
July
May
March
January
0
METHADONE CLINICS 1
buprenorphine
14
July 2016
AGE
30%
20-29
26%
30-39
40-49
22%
50-59
22%
None
June 2016
DRUG RELATED DEATHS
2015
2014
100
46
39
GENDER
RACE
2%2%
22%
White
Female
Black
Male
Hispanic
78%
96%

Opioids
26%
30%
Benzodiazepines
Antidepresants
Anticonvulsants
1%
3%
Antihistamines
8%
16%
Hypnotics
Illegal
16%
101
MONTGOMERY
HEALTH PROFILE
DEATHS BY WEEKDAY
USE
Saturday
Friday
Thursday
Wednesday
Tuesday
Monday
Sunday
Hep B Acute
<5
Hep B Chronic 529
HIV
156
10
15
20
25
30
35
40

ABUSE
Drug Abuse
708
Alcohol Abuse 287
DEATHS BY MONTH
Inpatient hospital
Outpatient
November
September
July
May
7
2
4
31

of Health
March
January
0
10
15
20
3%
16-19
20-29
12%
21%
19%
30-39
40-49
23%
20%

METHADONE CLINICS 6
buprenorphine
80
AGE
2%
25
50-59
60-69
70>
102

Adult Drug Court
Veterans Court
June 2016
DRUG RELATED DEATHS
2015 171
2014 161
RACE
GENDER
10%
2%
White
37%
Female
Black
Male
63%
88%

2%
2%
6%
1%
Opioids
4%
Benzodiazepines
Antidepressants
35%
6%
Anticonvulsants
Antihistamines
Muscle Relaxers
21%
Antipsychotics
Hypnotics
23%
Barbituates
103
Hispanic
MONTOUR
DEATHS BY WEEKDAY
HEALTH PROFILE
GENDER
Saturday
Thursday
33%
Tuesday
67%
Sunday
0
Male
Hep B Acute
<5
Hep B Chronic 8
HIV
0

ABUSE
DEATHS BY MONTH
Novemer
September
July
May
March
January
Drug Abuse
12
Alcohol Abuse 8
Outpatient
0

of Health
AGE
8%
8%
Female
USE
20-29
17%

buprenorphine
3
30-39
40-9
34%
33%
50-59

July 2016
60-69

None
Opioids
33%
44%
Benzodiazepines
Antidepresants
Anticonvulsants
11%
Illegal
6% 6%
104

June 2016
DRUG RELATED DEATHS
2015
12
NORTHAMPTON
HEALTH PROFILE
DEATHS BY TIME
USE
50
40
30
Hep B Acute
7
Hep B Chronic 112
HIV
37
20
10
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
398
Alcohol Abuse 253
DEATHS BY WEEKDAY
Saturday
Fiday
Thursday
Wednesday
Tuesday
Monday
Sunday
Outpatient
5
of Health
0
10
15
20

METHADONE CLINICS 1
buprenorphine
16
DEATHS BY MONTH

July 2016
November
September
July
May
March
January
Adult Drug Court

June 2016
0
10
12
DRUG RELATED DEATHS

2015
2014
105
71
28
AGE
1%
1%
7%
GENDER
16-19
20-29
23%
30-9
25%
28%
40-49
23%
Male
72%
50-59
20%
Female
60-69
MARITAL STATUS
RACE
3%
6%
Single
20%
51%
26%
10%
Married
White
Divorced
Black
Widowed
84%

Opioids
29%
30%
Benzodiazpines
Antidepressants
Anticonvulsants
Antihistamines
2%
4%
14%
5%
Antipsychotics
Illegal
16%
106
Hispanic
NORTHUMBERLAND
HEALTH PROFILE
DEATHS BY WEEKDAY
6
4
2
0
USE
Hep B Acute
0
Hep B Chronic 20
HIV
4
DEATHS BY MONTH

ABUSE
4
2
Drug Abuse
121
Alcohol Abuse 37

Outpatient
GENDER

of Health
Female
37%
63%
Male
METHADONE CLINICS 1
buprenorphine
3
DEATHS BY DRUG CASSIFICATION

Opioids
22%
36%
4%
Benzodiazepines
Antidepressants
Anticonvulsants
7%
13%
Muscle Relaxers
18%
Illegal

July 2016
Adult Drug Court
Juvenile Drug Court (Co-occurring)
Veterans Court
June 2016
DRUG RELATED DEATHS
2015
107
16
PERRY
HEALTH PROFILE
included in the calculation of the state-wide statistics. Also, all the county
data for the less than 10 drug deaths has been compiled in charts following
the individual county charts.
USE
Hep B Acute
0
Hep B Chronic 19
HIV
3

ABUSE
Drug Abuse
97
Alcohol Abuse 78
Outpatient

of Health
buprenorphine
None
July 2016
None
June 2016
DRUG RELATED DEATHS
2015
2014
108
<10
<10
PHILADELPHIA
HEALTH PROFILE
USE
DEATHS BY TIME
Hep B Acute
17
Hep B Chronic 1,084
HIV
2,056
400
200

ABUSE
0
8AM-4PM
4PM-12AM
12AM-8AM
Drug Abuse
2,532
Alcohol Abuse 1,085
DEATHS BY WEEKDAY
Inpatient Hospital
Outpatient
150
100
37
5
10
78
50

of Health

METHADONE CLINICS 16
buprenorphine
172
DEATHS BY MONTH
80

60
40
20
Adult Drug Court

Juvenile Drug Court
Veterans Court
June 2016
109
DRUG RELATED DEATHS

2015 702
2014 611
0%
AGE
2%
1%
GENDER
1-5
9%
16-19
19%
20-29
25%
30-39
23%
28%
40-49
21%
Male
72%
50-59
Female
60-69
MARITAL
RACE
4%
0%
Sngle
16%
Married
15%
White
33%
Divorced
65%
Black
67%
Widowed

Opioids
Benzodiazepines
21%
0%
30%
Antidepressants
Antihistamines
1%
2%
Antipsychotics
4%
Anticonvulsants
2%
7%
Muscle Relaxers
11%
22%
Barbituates
Hypnotics
110
Asian
PIKE
HEALTH PROFILE

USE
Hep B Acute
<5
Hep B Chronic 27
HIV
20

ABUSE
Drug Abuse
113
Alcohol Abuse 66
Outpatient

of Health
buprenorphine
5
July 2016
None
June 2016
DRUG RELATED DEATHS
2015
2014
111
<10
<10
POTTER
HEALTH PROFILE
USE
Hep B Acute
0
Hep B Chronic <5
HIV
1

ABUSE
Drug Abuse
65
Alcohol Abuse 25
Outpatient

of Health
buprenorphine
None
July 2016
Adult Drug Court
June 2016
DRUG RELATED DEATHS
2015
2014
112
<10
0
SCHUYLKILL
HEALTH PROFILE
USE
DEATHS BY TIME
15
Hep B Acute
7
Hep B Chronic 51
HIV
15
10
5
0
8AM-4PM
4PM-12AM

ABUSE
12AM-8AM
Drug Abuse
419
Alcohol Abuse 162
DEATHS BY WEEKDAY
Saturday
Thursday

Outpatient
5
Tuesday
Sunday
0
DEATHS BY MONTH

of Health
buprenorphine
6
October
July
April
January
0

July 2016
GENDER
AGE
4%
22% 22%
26% 26%
None
20-29
30-39
40-49
50%
50%
Female
Male

June 2016
50-59
DRUG RELATED DEATHS
60-69
2015
113
24
MARITAL STATUS
RACE
18%
Single
8%
Married
50%
32%
Divorced
White
92%
Black
29%
32%
Opioids
Benzodiazepines
Muscle Relaxer
Illegal
3%
36%
114
SNYDER
HEALTH PROFILE
USE
Hep B Acute
0
Hep B Chronic 7
HIV
0

ABUSE
Drug Abuse
45
Alcohol Abuse 19
Outpatient
1
of Health
buprenorphine
None
July 2016
Adult Drug Court (Snyder/Union)

June 2016
DRUG RELATED DEATHS
2015
115
<10
SOMERSET
HEALTH PROFILE
USE
DEATHS BY WEEKDAY
4.5
Hep B Acute
0
Hep B Chronic 13
HIV
6
4
3.5
3

ABUSE
2.5
2
1.5
Drug Abuse
244
Alcohol Abuse 167
1
0.5
0
Sunday
Monday
Friday
Saturday
Outpatient
2
of Health
DEATHS BY MONTH
3.5

buprenorphine
None
3
2.5
2

July 2016
1.5
1
0.5
0
None
June 2016
DRUG RELATED DEATHS
2015
116
16
AGE
30-39
40-49
50-59
60-69
6%
44%
38%
12%
GENDER
Female
Male
37%
63%

Opioids
Benzodiazepines
Antihistamines
Antidepressants
Barbituates
Illegal
11%
4%
15%
45%
8%
2%
15%
117
Anticonvulsants
SULLIVAN
HEALTH PROFILE
NONE
USE
Hep B Acute
0
Hep B Chronic 0
HIV
1

ABUSE
Drug Abuse
2
Alcohol Abuse 3
Outpatient

of Health
buprenorphine
None
July 2016
Adult Drug Court (Wyoming/Sullivan
Hybrid)
June 2016
DRUG RELATED DEATHS
2015
2014
118
None
<10
SUSQUEHANNA
HEALTH PROFILE

USE
Hep B Acute
<5
Hep B Chronic <5
HIV
1

ABUSE
Drug Abuse
47
Alcohol Abuse 36
Outpatient

of Health
buprenorphine
None
July 2016
None
June 2016
DRUG RELATED DEATHS
2015
2014
119
<10
12
TIOGA
HEALTH PROFILE
USE
Hep B Acute
0
Hep B Chronic <5
HIV
0

ABUSE
Drug Abuse
71
Alcohol Abuse 19
Inpatient Hospital
1
Outpatient
1
of Health
buprenorphine
None
July 2016
None
June 2016
DRUG RELATED DEATHS
120
2015
2014
<10
<10
UNION
HEALTH PROFILE
USE
Hep B Acute
<5
Hep B Chronic 46
HIV
12

ABUSE
Drug Abuse
32
Alcohol Abuse 21
Outpatient
3
of Health
METHADONE CLINICS 1
buprenorphine
1
July 2016
Adult Drug Court (Snyder/Union)

June 2016
DRUG RELATED DEATHS
2015
2014
121
<10
<10
VENANGO
HEALTH PROFILE
DEATHS BY MONTH
3.5
3
USE
2.5
2
1.5
Hep B Acute
0
Hep B Chronic <5
HIV
2
1
0.5
0

ABUSE
Drug Abuse
231
Alcohol Abuse 147
DEATHS BY WEEKDAY
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
Outpatient
6
of Health
buprenorphine
4
July 2016
AGE

9%
None
20-29
36%
30-39
40-49
46%
50-59

June 2016
DRUG RELATED DEATHS
9%
2015
2014
122
11
10
GENDER
Female
50%
50%
Male
MARITAL STATUS
27%
Single
46%
Married
Divorced
27%

Opioids
22%
25%
Anticonvulsants
Benzodiazepines
10%
5%
5%
13%
Antidepressants
Antipsychotics
Antihistamines
Illegal
20%
123
WARREN
HEALTH PROFILE
USE
NONE
Hep B Acute
0
Hep B Chronic <5
HIV
0

ABUSE
Drug Abuse
99
Alcohol Abuse 80
Inpatient Hospital
Outpatient
1
2

of Health
buprenorphine
1
July 2016
Adult Drug Court

June 2016
DRUG RELATED DEATHS
2015
2014
124
None
<10
WASHINGTON
HEALTH PROFILE
USE
DEATHS BY TIME
40
Hep B Acute
<5
Hep B Chronic 32
HIV
19
30
20
10
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
296
Alcohol Abuse 79
DEATHS BY WEEKDAY
15
10
5
0

Outpatient
6
of Health
DEATHS BY MONTH
10
METHADONE CLINICS 1
buprenorphine
33

July 2016
AGE
16-19
20-29
30-39
22%
40-49
50-59
60-69

Adult Drug Court (Co-occurring)
Veterans Court
1%
1% 18%

June 2016
26%
32%
DRUG RELATED DEATHS

125
2015
2014
73
33
GENDER
Female
Male
32%
68%
RACE
White
Black
3%
97%

Opioids
Benzodiazepines
Illegal
38%
47%
15%
126
WAYNE
HEALTH PROFILE
DEATHS BY TIME
USE
14
12
10
8
6
4
2
0
Hep B Acute
<5
Hep B Chronic 30
HIV
3
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
141
Alcohol Abuse 115
DEATHS BY WEEKDAY
5
4
3
2
1
0
Outpatient
2
of Health
buprenorphine
2
DEATHS BY MONTH

July 2016
5
4
3
2
1
0
None
June 2016
DRUG RELATED DEATHS
2015
2014
127
18
14
GENDER
AGE
Female
20-29
30-39
40-49
50-59
Male
60-69
6%
28%
22%
33%
11%
72%
28%
MARITAL STATUS
Single
Married
Divorced
Widowed
5%
11%
56%
28%

Opioids
Benzodiazepines
Antidepressants
Anticonvulsants
Antihistamines
Muscle Relaxers
Antipsychotics
Illegal
13%
4%
4%
40%
6%
4%
10%
19%
128
WESTMORELAND
HEALTH PROFILE
TIME
USE
80
60
Hep B Acute
<5
Hep B Chronic 43
HIV
18
40
20
0
8AM-4PM
4PM-12AM
12AM-8AM

ABUSE
Drug Abuse
415
Alcohol Abuse 183
WEEKDAY
25
Outpatient
11
20
15
10
5

of Health

METHADONE CLINICS 2
buprenorphine
45
MONTH

July 2016
16
14
12
10
8
6
4
2
0

Adult Drug Court
Family Drug Court
Veterans Court
June 2016
DRUG RELATED DEATHS
129
2015
2014
126
87
AGE
3%
1%
17%
GENDER
2%
1-4
Female
16-19
23%
20-29
30-39
29%
Male
25%
38%
40-49
62%
50-59
MARITAL STATUS
Single
Married
Divorced
RACE
3%
14%
58%
25%
White
Black

Opioids
Benzodiazepines
24%
27%
Antidepressants
Anticonvulsants
1%
Antihistamines
0%
14%
2%
4%
Antipsychotics
Muscle Relaxers
6%
8%
Barbituates
14%
Hypnotics
130
Widowed
WYOMING
HEALTH PROFILE

USE
Hep B Acute
0
Hep B Chronic <5
HIV
1

ABUSE
Drug Abuse
89
Alcohol Abuse 59
Outpatient
1
of Health
buprenorphine
1
July 2016
Adult Drug Court

(Wyoming/Sullivan)
June 2016
DRUG RELATED DEATHS
2015
2014
131
<10
17
YORK
HEALTH PROFILE
DEATHS BY WEEKDAY
USE
20
15
10
5
Hep B Acute
9
Hep B Chronic 120
HIV
83

ABUSE
Drug Abuse
697
Alcohol Abuse 379
DEATHS BY MONTH
20
15
Outpatient
18
10
5
0

of Health
METHADONE CLINICS 1
buprenorphine
22
AGE
2%
5%
16-19
14%
20-29
36%

30-39
14%
29%
40-49
50-59
Adult Drug Court

Juvenile Drug Court
Veterans Court
June 2016
DRUG RELATED DEATHS
132
2015
2014
99
120
MARITAL STATUS
GENDER
Female
2%
RACE
Single
Married
Divorced
8%
Male
11%
White
12%
Black
39%
Hispanic
90%
61%
77%

Opioids
Benzodiazepines
27%
28%
Anticonvulsants
Antidepressants
Muscle Relaxers
2%
15%
2%
4%
15%
Antihistamines
Antipsychotics
7%
Illegal
133
More needs to be done. Drug deaths represent approximately 10 percent of the drug abuse issue.
Until hospitals, EMS, poison control centers, 911 call centers, law enforcement and all who prescribe
and administer Narcan report on drug overdoses where the person survives, and on the judicial
results of those who sell drugs, we are doing nothing more than establishing a drug policy which
deals with drug use one grave at a time.
The world is a dangerous place to live; not because of the people who are evil, but because of the people who don't
do anything about it. Albert Einstein
134

2015 DRUG REPORT Pennsylvania State Coroners Association

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

2015 DRUG REPORT Pennsylvania State Coroners Association

Uploaded by

Copyright:

Available Formats

Pennsylvania State Coroners Association

Report on Overdose Death

Mt. Chestnut Presb. Church

Patients Continue to Receive Prescription Opioids Following Overdose, MD Magazine, www.hcplive.com

Number of Reported Drug Deaths by County, 2015

Number of Reported Drug Deaths by Region, 2015

Number of Reported Drug Deaths Per 100,000 Population by

Change in Number of Reported Drug Deaths from 2014 to 2015

Number of Reported Drug Deaths

OVERDOSES STATEWIDE BY SPECIFIC DRUGS

DEATHS BY DRUG CLASSIFICATION

DEATHS BY TIME OF DAY

ADMISSIONS FOR SUBSTANCE

SOURCE: Pennsylvania and County

NARCOTIC TREATMENT PROGRAMS

Tuesday Wednesday Thursday

METHADONE CLINICS None

DEATHS BY TIME OF DAY

PROBLEM SOLVING COURTS

SOURCE: PA Unified Judicial System

DRUG RELATED DEATHS

DEATHS BY DRUG CLASSIFICATION

ADMISSIONS FOR SUBSTANCE

SOURCE: Pennsylvania and County

Tuesday Wednesday Thursday

SOURCE: PA DDAP 2015, SAMSHA

PROBLEM SOLVING COURTS

Adult Drug Court

SOURCE: PA Unified Judicial System

DRUG RELATED DEATHS

DEATHS BY DRUG CLASSIFICATION

ADMISSIONS FOR SUBTANCE ABUSE

SOURCE: Pennsylvania and County

NARCOTIC TREATMENT PROGRAMS

SOURCE: PA DDAP 2015, SAMSHA

PROBLEM SOLVING COURTS

DEATHS BY DRUG CLASSIFICATION

ADMISSIONS FOR SUBSTANCE

SOURCE: Pennsylvania and County

NARCOTIC TREATMENT PROGRAMS

PROBLEM SOLVING COURTS

DEATH BY DRUG CLASSIFICATION

ADMISSIONS FOR SUBSTANCE

SOURCE: Pennsylvania and County

ADMISSIONS FOR SUBSTANCE

TREATMENT FACILITIES (AS OF 6/13)

SOURCE: PA DDAP 2015, SAMSHA

PROBLEM SOLVING COURTS

DEATHS BY DRUG CLASSIFICATION

ADMISSIONS FOR SUBSTANCE

SOURCE: Pennsylvania and County

NARCOTIC TREATMENT PROGRAMS

PROBLEM SOLVING COURTS

Adult Drug Court

SOURCE: PA Unified Judicial System

DRUG RELATED DEATHS

DEATHS BY DRUG CLASSIFICATION

ADMISSIONS FOR SUBSTANCE

SOURCE: Pennsylvania and County

NARCOTIC TREATMENT PROGRAMS

Tuesday Wednesday Thursday

METHADONE CLINICS None

PROBLEM SOLVING COURTS

Adult Drug Court (hybrid)